Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Lessi

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Neuro-Oncology Advances|June 29, 2026
Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastomaMariangela Morelli, Francesca Di Lorenzo, Francesca Marchetto, et al.
Oncotarget|May 29, 2018
Levels of miR-126 and miR-218 are elevated in ductal carcinoma <i>in situ</i> (DCIS) and inhibit malignant potential of DCIS derived cellsStefano Volinia, Valeria Bertagnolo, Silvia Grassilli, et al.
Cell Death Discovery|April 13, 2026
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerabilitySara Franceschi, Mariangela Morelli, Francesca Lessi, et al.
Frontiers in Oncology|July 13, 2019
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast CancerMarco La Ferla, Francesca Lessi, Paolo Aretini, et al.
Nature Communications|February 14, 2025
Learning and actioning general principles of cancer cell drug sensitivityFrancesco Carli, Pierluigi Di Chiaro, Mariangela Morelli, et al.
Frontiers in Oncology|May 9, 2025
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Frontiers in Oncology|September 22, 2022
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Neuro-Oncology Advances|June 29, 2026
Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastomaMariangela Morelli, Francesca Di Lorenzo, Francesca Marchetto, et al.
Oncotarget|May 29, 2018
Levels of miR-126 and miR-218 are elevated in ductal carcinoma <i>in situ</i> (DCIS) and inhibit malignant potential of DCIS derived cellsStefano Volinia, Valeria Bertagnolo, Silvia Grassilli, et al.
Cell Death Discovery|April 13, 2026
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerabilitySara Franceschi, Mariangela Morelli, Francesca Lessi, et al.
Frontiers in Oncology|July 13, 2019
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast CancerMarco La Ferla, Francesca Lessi, Paolo Aretini, et al.
Nature Communications|February 14, 2025
Learning and actioning general principles of cancer cell drug sensitivityFrancesco Carli, Pierluigi Di Chiaro, Mariangela Morelli, et al.
Frontiers in Oncology|May 9, 2025
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Frontiers in Oncology|September 22, 2022
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Pageof 6